Evidence map›Paper›PMID 32098688›Full record

ArticleDiagnostic microbiology and infectious disease2020

Core genome MLST and resistome analysis of Klebsiella pneumoniae using a clinically amenable workflow.

Madiha Fida, Scott A Cunningham, Matthew P Murphy, Robert A Bonomo, Kristine M Hujer, Andrea M Hujer, Barry N Kreiswirth, Nicholas Chia, Patricio R Jeraldo, Heidi Nelson and 5 more

Abstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Madiha FidaDivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN. Electronic address: fida.madiha@mayo.edu.
Scott A CunninghamDivision of Clinical Microbiology, Mayo Clinic, Rochester, MN.
Matthew P MurphyDivision of Clinical Microbiology, Mayo Clinic, Rochester, MN.
Robert A BonomoLouis Stokes Cleveland Department of Veteran Affairs Medical Center, Cleveland, OH; Department of Medicine, Case Western Reserve University, Cleveland, OH; Departments of Pharmacology, Biochemistry, Molecular Biology and Microbiology, and the Center for Proteomics and Bioinformatics, Case Western Reserve University, Cleveland, OH, and CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH.
Kristine M HujerLouis Stokes Cleveland Department of Veteran Affairs Medical Center, Cleveland, OH; Department of Medicine, Case Western Reserve University, Cleveland, OH.
Andrea M HujerLouis Stokes Cleveland Department of Veteran Affairs Medical Center, Cleveland, OH; Department of Medicine, Case Western Reserve University, Cleveland, OH.
Barry N KreiswirthPublic Health Research Institute, Rutgers University, Newark, NJ.
Nicholas ChiaCenter for Individualized Medicine, Mayo Clinic, Rochester, MN; Department of Surgery, Mayo Clinic, Rochester, MN.
Patricio R JeraldoCenter for Individualized Medicine, Mayo Clinic, Rochester, MN; Department of Surgery, Mayo Clinic, Rochester, MN.
Heidi NelsonCenter for Individualized Medicine, Mayo Clinic, Rochester, MN; Department of Surgery, Mayo Clinic, Rochester, MN.
Nicole M ZinsmasterDivision of Clinical Microbiology, Mayo Clinic, Rochester, MN.
Nikhil ToraskarOpGen Inc, Gaithersburg, MD.
Weizhong ChangOpGen Inc, Gaithersburg, MD.
Robin PatelDivision of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, MN; Division of Clinical Microbiology, Mayo Clinic, Rochester, MN.
Antibacterial Resistance Leadership Group

Funding

Antibacterial Resistance Leadership Group (ARLG)UM1AI104681 · NIAID · DUKE UNIVERSITY · PI Vance G. Fowler, Henry F HENRY CHAMBERS · 2013 to 2026
$180.8M
Understanding B-Lactam Resistance in Acinetobacter baumanniiR01AI072219 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI ROBERT A. BONOMO, Philip N. Rather · 2007 to 2026
$6.6M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
A Mechanism-Based Approach to Metallo-beta-Lactamase InhibitionR01AI100560 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A., SPENCER, JAMES · 2012 to 2022
$4.4M
Genomic Approach to Vaccine Design for Proteus mirabilisF32AI068324 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PEARSON, MELANIE M. · 2007 to 2008
$101k
The Continuing Challenge of Carbapenemases in K. pneumoniae: KPC-2 & NDM-1I01BX001974 · VA · LOUIS STOKES CLEVELAND VA MEDICAL CENTER · PI BONOMO, ROBERT A. · 2013 to 2024
–
BLRD VA I01 BX001974NIAID NIH HHS F32 AI068324NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI072219NIAID NIH HHS R01 AI100560NIAID NIH HHS UM1 AI104681
6 · The paper itself

Abstract

Whole genome sequencing (WGS) is replacing traditional microbiological typing methods for investigation of outbreaks in clinical settings. Here, we used a clinical microbiology laboratory core genome multilocus sequence typing (cgMLST) workflow to analyze 40 isolates of K. pneumoniae which are part of the Antimicrobial Resistance Leadership Group (ARLG) isolate collection, alongside 10 Mayo Clinic K. pneumoniae isolates, comparing results to those of pulsed-field gel electrophoresis (PFGE). Additionally, we used the WGS data to predict phenotypic antimicrobial susceptibility (AST). Thirty-one of 40 ARLG K. pneumoniae isolates belonged to the same PFGE type, all of which, alongside 3 isolates of different PFGE types, formed a large cluster by cgMLST. PFGE and cgMLST were completely concordant for the 10 Mayo Clinic K. pneumoniae isolates. For AST prediction, the overall agreement between phenotypic AST and genotypic prediction was 95.6%.

Indexed as

Genome, BacterialMultilocus Sequence TypingAnti-Bacterial AgentsBacterial Typing Techniquesbeta-LactamasesElectrophoresis, Gel, Pulsed-FieldGenotypeHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsPhenotypeWhole Genome SequencingWorkflowAnti-Bacterial Agentsbeta-LactamasesCore genome multilocus sequence typingKlebsiella pneumoniaePulse field gel electrophoresisWhole genome sequencing

Identifiers

PMID32098688
PMCPMC7422488

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.